2002
DOI: 10.1002/chin.200221114
|View full text |Cite
|
Sign up to set email alerts
|

ChemInform Abstract: Biphenylsulfonamide Endothelin Receptor Antagonists. Part 3. Structure—Activity Relationship of 4′‐Heterocyclic Biphenylsulfonamides.

Abstract: ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…Introduction of fluorine atoms into the skeletons of oxindoles has attracted much attention from organic chemists and medicinal chemists, because this transformation significantly changes the physical, chemical and biological properties, compared to their parent non‐fluorinated oxindoles, often to an advantage . For example, compound 1 is a potent and selective EP3 receptor antagonist; compound 2 inhibits the activity of endothelin and is useful as an antihypertensive; compound 3 has anticancer activity; compound 4 was tested as a preventive and therapeutic agent for nervous system disorders; compound 5 could act as an ErbB kinase inhibitor (Figure ). The key feature of these biologically active compounds is that they possess a 3,3‐difluoro‐2‐oxindole subunit.…”
Section: Figurementioning
confidence: 99%
“…Introduction of fluorine atoms into the skeletons of oxindoles has attracted much attention from organic chemists and medicinal chemists, because this transformation significantly changes the physical, chemical and biological properties, compared to their parent non‐fluorinated oxindoles, often to an advantage . For example, compound 1 is a potent and selective EP3 receptor antagonist; compound 2 inhibits the activity of endothelin and is useful as an antihypertensive; compound 3 has anticancer activity; compound 4 was tested as a preventive and therapeutic agent for nervous system disorders; compound 5 could act as an ErbB kinase inhibitor (Figure ). The key feature of these biologically active compounds is that they possess a 3,3‐difluoro‐2‐oxindole subunit.…”
Section: Figurementioning
confidence: 99%